Search research articles
Contact Us
Filters
Showing results (491-500 of 506) with videos related to
Page
of 51
Sort By:
Nature Medicine
|
November 13, 2012
Targeted estrogen delivery reverses the metabolic syndrome
Brian Finan, Bin Yang, Nickki Ottaway, et al.
Diabetes
|
January 12, 2013
Fibroblast growth factor 21 mediates specific glucagon actions
Kirk M Habegger, Kerstin Stemmer, Christine Cheng, et al.
Nature Medicine
|
December 9, 2014
A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents
Brian Finan, Bin Yang, Nickki Ottaway, et al.
Cell Reports
|
January 23, 2020
Adaptive Thermogenesis in Mice Is Enhanced by Opsin 3-Dependent Adipocyte Light Sensing
Gowri Nayak, Kevin X Zhang, Shruti Vemaraju, et al.
Nature Immunology
|
January 16, 2026
A GDF-15-GFRAL axis controls autoimmune T cell responses during neuroinflammation
Jana K Sonner, Audrey Kahn, Lars Binkle-Ladisch, et al.
Nature Communications
|
May 19, 2021
A BAFF/APRIL axis regulates obesogenic diet-driven weight gain
Calvin C Chan, Isaac T W Harley, Paul T Pfluger, et al.
Obesity (Silver Spring, Md.)
|
February 28, 2014
Hyperphagia: current concepts and future directions proceedings of the 2nd international conference on hyperphagia
Steven B Heymsfield, Nicole M Avena, Leslie Baier, et al.
Cell Metabolism
|
September 26, 2017
Molecular Integration of Incretin and Glucocorticoid Action Reverses Immunometabolic Dysfunction and Obesity
Carmelo Quarta, Christoffer Clemmensen, Zhimeng Zhu, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
October 26, 2005
PYY3-36 as an anti-obesity drug target
M M Boggiano, P C Chandler, K D Oswald, et al.
Nature Medicine
|
March 5, 2020
Joint international consensus statement for ending stigma of obesity
Francesco Rubino, Rebecca M Puhl, David E Cummings, et al.
Page
of 51
Search research articles
Search
Showing results (491-500 of 506) with videos related to
Sort By:
Page
of 51
Nature Medicine
|
November 13, 2012
Targeted estrogen delivery reverses the metabolic syndrome
Brian Finan, Bin Yang, Nickki Ottaway, et al.
Diabetes
|
January 12, 2013
Fibroblast growth factor 21 mediates specific glucagon actions
Kirk M Habegger, Kerstin Stemmer, Christine Cheng, et al.
Nature Medicine
|
December 9, 2014
A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents
Brian Finan, Bin Yang, Nickki Ottaway, et al.
Cell Reports
|
January 23, 2020
Adaptive Thermogenesis in Mice Is Enhanced by Opsin 3-Dependent Adipocyte Light Sensing
Gowri Nayak, Kevin X Zhang, Shruti Vemaraju, et al.
Nature Immunology
|
January 16, 2026
A GDF-15-GFRAL axis controls autoimmune T cell responses during neuroinflammation
Jana K Sonner, Audrey Kahn, Lars Binkle-Ladisch, et al.
Nature Communications
|
May 19, 2021
A BAFF/APRIL axis regulates obesogenic diet-driven weight gain
Calvin C Chan, Isaac T W Harley, Paul T Pfluger, et al.
Obesity (Silver Spring, Md.)
|
February 28, 2014
Hyperphagia: current concepts and future directions proceedings of the 2nd international conference on hyperphagia
Steven B Heymsfield, Nicole M Avena, Leslie Baier, et al.
Cell Metabolism
|
September 26, 2017
Molecular Integration of Incretin and Glucocorticoid Action Reverses Immunometabolic Dysfunction and Obesity
Carmelo Quarta, Christoffer Clemmensen, Zhimeng Zhu, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
|
October 26, 2005
PYY3-36 as an anti-obesity drug target
M M Boggiano, P C Chandler, K D Oswald, et al.
Nature Medicine
|
March 5, 2020
Joint international consensus statement for ending stigma of obesity
Francesco Rubino, Rebecca M Puhl, David E Cummings, et al.
Page
of 51